These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 33891298)

  • 1. Effects of local laser treatment on vulvovaginal atrophy among women with breast cancer: a prospective study with long-term follow-up.
    Veron L; Wehrer D; Annerose-Zéphir G; Suciu V; Delaloge S; Pistilli B; Chaltiel D; Pautier P
    Breast Cancer Res Treat; 2021 Jul; 188(2):501-509. PubMed ID: 33891298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microablative Fractional CO
    Salvatore S; Nappi RE; Casiraghi A; Ruffolo AF; Degliuomini R; Parma M; Leone Roberti Maggiore U; Athanasiou S; Candiani M
    Clin Breast Cancer; 2021 Oct; 21(5):e539-e546. PubMed ID: 33745867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sexual function after fractional microablative CO₂ laser in women with vulvovaginal atrophy.
    Salvatore S; Nappi RE; Parma M; Chionna R; Lagona F; Zerbinati N; Ferrero S; Origoni M; Candiani M; Leone Roberti Maggiore U
    Climacteric; 2015 Apr; 18(2):219-25. PubMed ID: 25333211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbon dioxide laser treatment for vulvovaginal atrophy in women treated for breast cancer: Preliminary results of the feasibility EPIONE trial.
    Hersant B; Werkoff G; Sawan D; Sidahmed-Mezi M; Bosc R; La Padula S; Kalsoum S; Ouidir N; Meningaud JP; Belkacemi Y
    Ann Chir Plast Esthet; 2020 Jul; 65(4):e23-e31. PubMed ID: 32513482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fractional microablative CO2 laser for vulvovaginal atrophy in women treated with chemotherapy and/or hormonal therapy for breast cancer: a retrospective study.
    Pagano T; De Rosa P; Vallone R; Schettini F; Arpino G; De Placido S; Nazzaro G; Locci M; De Placido G
    Menopause; 2016 Oct; 23(10):1108-13. PubMed ID: 27648595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-Term Efficacy and Safety of Non-Ablative Laser Treatment Alone or with Estriol or Moisturizers in Postmenopausal Women with Vulvovaginal Atrophy.
    Alvisi S; Lami A; Baldassarre M; Lenzi J; Mancini I; Seracchioli R; Meriggiola MC
    J Sex Med; 2022 May; 19(5):761-770. PubMed ID: 35370104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of non-ablative CO
    Lami A; Alvisi S; Baldassarre M; Zanella S; Amati V; Seracchioli R; Meriggiola MC
    Arch Gynecol Obstet; 2024 Apr; 309(4):1575-1583. PubMed ID: 38253692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fractional CO2 laser for vulvovaginal atrophy (VVA) dyspareunia relief in breast cancer survivors.
    Pieralli A; Fallani MG; Becorpi A; Bianchi C; Corioni S; Longinotti M; Tredici Z; Guaschino S
    Arch Gynecol Obstet; 2016 Oct; 294(4):841-6. PubMed ID: 27170261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fractional microablative CO2 laser in breast cancer survivors affected by iatrogenic vulvovaginal atrophy after failure of nonestrogenic local treatments: a retrospective study.
    Pagano T; De Rosa P; Vallone R; Schettini F; Arpino G; Giuliano M; Lauria R; De Santo I; Conforti A; Gallo A; Nazzaro G; De Placido S; Locci M; De Placido G
    Menopause; 2018 Jun; 25(6):657-662. PubMed ID: 29286986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding the Benefits of CO
    Jankovic S; Rovcanin M; Tomic A; Jurisic A; Milovanovic Z; Zamurovic M
    Medicina (Kaunas); 2024 Jun; 60(7):. PubMed ID: 39064488
    [No Abstract]   [Full Text] [Related]  

  • 11. Vaginal CO
    Pearson A; Booker A; Tio M; Marx G
    Breast Cancer Res Treat; 2019 Nov; 178(1):135-140. PubMed ID: 31377895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study.
    Salvatore S; Nappi RE; Zerbinati N; Calligaro A; Ferrero S; Origoni M; Candiani M; Leone Roberti Maggiore U
    Climacteric; 2014 Aug; 17(4):363-9. PubMed ID: 24605832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment to External Labia and Vaginal Canal With CO2 Laser for Symptoms of Vulvovaginal Atrophy in Postmenopausal Women.
    Samuels JB; Garcia MA
    Aesthet Surg J; 2019 Jan; 39(1):83-93. PubMed ID: 29726916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaginal laser therapy for GSM/VVA: where we stand now - a review by the EUGA Working Group on Laser.
    Salvatore S; Ruffolo AF; Phillips C; Athanasiou S; Cardozo L; Serati M;
    Climacteric; 2023 Aug; 26(4):336-352. PubMed ID: 37395104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fractional Co
    Alexiades MR
    Lasers Surg Med; 2021 Feb; 53(2):185-198. PubMed ID: 32329093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fractional CO
    Siliquini GP; Tuninetti V; Bounous VE; Bert F; Biglia N
    Climacteric; 2017 Aug; 20(4):379-384. PubMed ID: 28503946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symptom severity and quality of life in the management of vulvovaginal atrophy in postmenopausal women.
    Panay N; Palacios S; Bruyniks N; Particco M; Nappi RE;
    Maturitas; 2019 Jun; 124():55-61. PubMed ID: 31097180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fractional Co2 laser for vulvo-vaginal atrophy in gynecologic cancer patients: A valid therapeutic choice? A systematic review.
    D'Oria O; Giannini A; Buzzaccarini G; Tinelli A; Corrado G; Frega A; Vizza E; Caserta D
    Eur J Obstet Gynecol Reprod Biol; 2022 Oct; 277():84-89. PubMed ID: 36037664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic quadripolar radiofrequency treatment of vaginal laxity/menopausal vulvo-vaginal atrophy: 12-month efficacy and safety.
    Vicariotto F; DE Seta F; Faoro V; Raichi M
    Minerva Ginecol; 2017 Aug; 69(4):342-349. PubMed ID: 28608667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of vulvovaginal atrophy of menopause: prevalence and symptoms in Italian women according to the EVES study.
    Nappi RE; Seracchioli R; Salvatore S; Cagnacci A; Di Paolantonio T; Busacca M;
    Gynecol Endocrinol; 2019 May; 35(5):453-459. PubMed ID: 30700188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.